Could less radiation be enough for HPV throat cancer? new study investigates
NCT ID NCT03777384
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at whether a lower dose of radiation can safely treat HPV-positive oropharynx (throat) cancer in people who have never smoked or smoked very little. Researchers will follow 75 patients for up to 5 years to see if the cancer stays away and how their quality of life is affected. The goal is to find out if reducing radiation can still be effective while causing fewer side effects.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
de-escalated radiotherapy
What this could lead to
If successful, this could confirm that lower-dose radiation is safe and effective for HPV+ throat cancer in non-smokers, reducing side effects while maintaining cancer control.
What could go wrong
This is an observational study, not a randomized trial, so results may not prove cause and effect. The small size (75 people) and specific population (non-smokers) limit how broadly the findings can be applied.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OROPHARYNGEAL CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Sanford Edith Cancer Center
Sioux Falls, South Dakota, 57104, United States
-
Sanford Roger Maris Cancer Center
Fargo, North Dakota, 58102, United States